Maximum Amikacin Dosing
For adults with normal renal function, the maximum daily dose of amikacin is 15 mg/kg/day (not to exceed 1.5 grams/day), typically administered as a single daily dose or divided into 7.5 mg/kg every 12 hours or 5 mg/kg every 8 hours. 1, 2
Standard Adult Dosing Parameters
- Weight-based maximum: 15 mg/kg/day is the absolute ceiling for total daily administration by all routes 1, 2
- Absolute maximum: 1.5 grams (1,500 mg) per day regardless of body weight, even in heavier patients 2
- Age adjustment required: Patients over 59 years should receive a reduced maximum of 10 mg/kg/day (750 mg) due to increased risk of ototoxicity and nephrotoxicity 1, 3, 4
Administration Schedules
The 15 mg/kg/day maximum can be administered via three approaches 2:
- Once daily: 15 mg/kg as single dose (preferred for concentration-dependent killing)
- Twice daily: 7.5 mg/kg every 12 hours
- Three times daily: 5 mg/kg every 8 hours
Pediatric Maximum Dosing
- Children and older infants: 15-30 mg/kg/day (maximum 1 gram/day) as single daily dose 1, 3
- Newborns: Loading dose of 10 mg/kg, then 7.5 mg/kg every 12 hours 2
Important caveat: The higher pediatric range (up to 30 mg/kg/day) is reserved for severe infections or special populations like cystic fibrosis patients with altered pharmacokinetics, and requires therapeutic drug monitoring 5
Special Clinical Contexts
Tuberculosis and Drug-Resistant Infections
For mycobacterial infections, the dosing paradigm differs slightly 1:
- Initial intensive phase: 15 mg/kg/day (1 gram maximum) given 5-7 days per week
- Continuation phase: After 2-4 months or culture conversion, reduce frequency to 2-3 times weekly while maintaining the 12-15 mg/kg per dose (not reducing the milligram amount)
Renal Impairment
Critical principle: Never reduce the milligram dose—only extend the dosing interval 1, 3, 4
- Maintain 12-15 mg/kg per dose but administer 2-3 times weekly instead of daily 1
- This preserves concentration-dependent bactericidal activity while preventing accumulation 1
- Administer after hemodialysis to avoid premature drug removal 1, 3
Critically Ill and Septic Patients
Emerging evidence suggests higher loading doses may be necessary in severe sepsis 6, 7:
- Loading doses of 25-30 mg/kg have been studied in septic shock patients to achieve adequate peak concentrations 7
- A 30 mg/kg loading dose achieved target peak levels (>60 mcg/mL) in 76% of critically ill patients without increased nephrotoxicity 7
- However, these exceed FDA-approved maximum dosing and should only be considered with therapeutic drug monitoring in life-threatening infections 7
Therapeutic Drug Monitoring Targets
To ensure the maximum dose is both effective and safe 3, 2:
- Peak levels: 25-35 mcg/mL for daily dosing; 65-80 mcg/mL for three-times-weekly dosing 3
- Trough levels: Must remain <5 mcg/mL to prevent toxicity 3, 2
- Timing: Measure peak 30-90 minutes after infusion; trough immediately before next dose 2
- Peak concentrations above 35 mcg/mL and trough concentrations above 10 mcg/mL should be avoided 2
Duration Limits
- Standard duration: 7-10 days is typical 2
- Extended therapy: If treatment beyond 10 days is necessary, amikacin use must be re-evaluated with mandatory monitoring of serum levels, renal function, and auditory/vestibular function 2
- Bone infections: Up to 6 months may be required for mycobacterial bone infections 1
Toxicity Monitoring Requirements
Baseline assessment before initiating maximum-dose therapy 1, 3:
- Audiogram and vestibular testing
- Romberg testing
- Serum creatinine measurement
Monthly monitoring during therapy 1, 3:
- Renal function assessment
- Questioning about auditory or vestibular symptoms
- Repeat audiogram if any eighth nerve toxicity symptoms develop
Common Pitfalls to Avoid
Do not use fixed 500 mg doses: This ignores body weight entirely and risks both underdosing (treatment failure) and overdosing (toxicity) 3, 5
Do not exceed 1.5 grams/day in standard therapy: Even in patients weighing >100 kg, the absolute maximum remains 1.5 grams unless treating drug-resistant tuberculosis or in research protocols with intensive monitoring 1, 2
Do not reduce the milligram dose in renal failure: This is the most critical error—extend the interval instead to maintain concentration-dependent killing 1, 3
Do not continue beyond 10 days without reassessment: Prolonged therapy dramatically increases ototoxicity risk (1.5-24% depending on duration) and nephrotoxicity risk (8.7% overall) 3, 2
Obesity Adjustment
For obese patients, calculate dose using adjusted body weight 3:
- Formula: Ideal body weight + 40% of excess weight
- This prevents excessive dosing while ensuring adequate tissue penetration
Absolute Contraindication
Pregnancy: Amikacin is absolutely contraindicated due to risk of fetal nephrotoxicity and congenital hearing loss 1, 3